| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
1e-13 |
| mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
6e-12 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-10 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-06 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-05 |